Orcoda Limited (ASX:ODA)

Sage Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	15	30	45	11	18	16
Market Cap Growth	-56.76%	-34.41%	313.79%	-38.42%	9.02%	59.31%
Enterprise Value	16	28	45	8	18	14
Last Close Price	0.08	0.17	0.27	0.07	0.12	0.14
PE Ratio	-	32.70	114.13	-	40.25	-
Forward PE	-	30.77	30.77	30.77	30.77	30.77
PS Ratio	0.72	1.18	2.26	0.68	2.32	8.86
PB Ratio	0.90	1.71	2.84	0.76	1.38	2.20
P/TBV Ratio	2.67	4.59	6.78	1.92	4.29	24.01
P/FCF Ratio	-	20.07	17.80	21.90	66.48	-
P/OCF Ratio	119.53	14.99	16.69	10.02	52.57	-
EV/Sales Ratio	0.77	1.13	2.27	0.49	2.35	7.87
EV/EBITDA Ratio	31.55	11.08	29.64	7.24	26.70	-
EV/EBIT Ratio	-	16.76	56.84	12.76	39.40	-
EV/FCF Ratio	-43.15	19.24	17.87	16.01	67.35	-
Debt / Equity Ratio	0.25	0.24	0.26	0.16	0.06	0.09
Debt / EBITDA Ratio	8.29	1.46	2.50	1.76	0.88	-
Debt / FCF Ratio	-	2.77	1.64	4.46	2.83	-
Asset Turnover	0.86	1.07	0.95	0.87	0.56	0.16
Inventory Turnover	94.86	-	-	-	-	-
Quick Ratio	1.25	1.41	1.95	1.60	1.62	2.66
Current Ratio	1.44	1.57	2.08	1.68	1.68	2.69
Return on Equity (ROE)	-7.54%	5.46%	2.62%	1.33%	4.51%	-69.56%
Return on Assets (ROA)	-1.88%	4.48%	2.37%	2.09%	2.09%	-13.21%
Return on Capital (ROIC)	-2.13%	5.11%	2.72%	2.59%	2.63%	-14.87%
Return on Capital Employed (ROCE)	-	8.40%	4.20%	3.90%	3.20%	-
Earnings Yield	-8.58%	3.06%	0.88%	-3.68%	2.48%	-42.31%
FCF Yield	-2.48%	4.98%	5.62%	4.57%	1.50%	-11.26%
Buyback Yield / Dilution	-0.53%	-4.95%	-8.18%	-14.87%	-18.61%	-18.78%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.